ARTICLE | Company News
Sun Pharmaceutical, Almirall deal
August 8, 2016 7:00 AM UTC
Sun Pharma granted Almirall rights to develop and commercialize tildrakizumab for psoriasis in Europe. Sun has exclusive, worldwide rights to the compound under a 2014 deal with Merck & Co. Inc. (NYS...